Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
Therapeutic effects of Ershen Zhenwu Decoction on inflammatory response and apoptotic pathways in chronic heart failure rats
Hits 296  Download times 198  Received:April 10, 2025  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2025.07.08
Key Words   chronic heart failure;Ershen Zhenwu Decoction;network pharmacology;molecular mechanism
Author NameAffiliationE-mail
LIU Yulong Anhui University of Chinese Medicine, Hefei 230012, China  
ZHANG Maomao Anhui University of Chinese Medicine, Hefei 230012, China  
WANG Xinyue Anhui University of Chinese Medicine, Hefei 230012, China  
GE Lan Anhui University of Chinese Medicine, Hefei 230012, China
The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China 
 
CHENG Xiaoyu The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China cxy478@163.com 
Abstract
    [Objective] To investigate the molecular mechanisms of Ershen Zhenwu Decoction(EZD) in treating chronic heart failure(CHF) through network pharmacology and experimental validation. [Methods] Active components and targets of EZD were screened using TCMSP and UniProt databases,while CHF-related targets were identified from GeneCards and OMIM databases. Protein-protein interaction networks of intersecting targets were constructed using STRING and visualized with Cytoscape 3.8.2. GO and KEGG enrichment analyses were performed using DAVID database. Thirty-five rats were randomly divided into normal,model,low-dose EZD,high-dose EZD,and control groups. The CHF model was established by intraperitoneal injection of doxorubicin. Serum levels of NT-proBNP,IL-6, and TNF-α were measured,and myocardial histopathology was examined by HE staining. The expression of apoptosis-related proteins was detected by Western blot and qRT-PCR. [Results] The study identified 85 active components,174 drug targets,and 118 drug-disease intersecting targets. Core targets included AKT1,Bcl-2,MMP9,TNF,CASP3,and IL-6. GO analysis revealed 810 enriched terms,while KEGG analysis showed significant associations with TNF,apoptosis,PI3K-Akt,and MAPK signaling pathways. The component-target network demonstrated strong associations between catechin,paeoniflorin,tanshinoneⅡA and the intersecting targets. Compared with normal group,model group showed elevated NT-proBNP,IL-6,TNF-α,Caspase-3 and Bax(P<0.05),decreased Bcl-2(P<0.05),and increased inflammatory infiltration. EZD treatment reversed these changes(P<0.05) and improved myocardial pathology. [Conclusion] EZD exerts cardioprotective effects in CHF rats,potentially through modulating inflammatory responses and inhibiting apoptosis.

You are the 2594262 visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.